Other genetic mutations known to be associated with similar clinically presenting diseases (FHM1 in CACNA1A, FHM2 in ATP1A2, and mutations within COL4A1 cause COL4A1-associated leukoencephalopathy) have been identified through follow-up testing requested by clinicians. The gene discussed is COL4A1; the disease is Leukoencephalopathy.